Pascal Besman, Chief Operating Officer of PharmaMar, talks about Lurbinectedin More Pronounced in Overall Survival | OS Endpoint is Preferable from Regulatory POV at Annual Meeting 2018
Lurbinectedin More Pronounced in Overall Survival | OS Endpoint is Preferable from Regulatory POV
